Peter Steven St, Director at Omrix Biopharmaceuticals, Inc. (OMRI), sold 2,750 shares at $29.49 ($81K) on 2007-08-13, disclosed to the SEC on 2007-08-14.
Open-market sale of $81k OMRI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PETX | SELL | 2018-09-21 | $909K | — | Filing → |
| PETX | SELL | 2018-07-30 | $50K | — | Filing → |
| PETX | SELL | 2018-05-01 | $58K | — | Filing → |